Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study

INTRODUCTION: Many commercially available glucagon products for treatment of severe hypoglycaemia require cumbersome reconstitution and potentially intimidating injection during an emergency. Nasal glucagon (NG) is a novel drug-device combination product consisting of a single-use dosing device that...

Descripción completa

Detalles Bibliográficos
Autores principales: Suico, Jeffrey G., Hövelmann, Ulrike, Zhang, Shuyu, Shen, Tong, Bergman, Brandon, Sherr, Jennifer, Zijlstra, Eric, Frier, Brian M., Plum-Mörschel, Leona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324463/
https://www.ncbi.nlm.nih.gov/pubmed/32514794
http://dx.doi.org/10.1007/s13300-020-00845-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324463/
https://www.ncbi.nlm.nih.gov/pubmed/32514794
http://dx.doi.org/10.1007/s13300-020-00845-7

Ejemplares similares